Concepedia

Ron Baldwin

RB

Statistics

Publications

4

Citations

202

H-Index

4

Active since

1994

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Ron Baldwin is an author at Ionis Pharmaceuticals (United States) specializing in medicine, neuropharmacology, and psychiatry.

Top concepts

Publications per year

1994–2018

4

Publications

4

Nocturnal bruxing events: a report of normative data and cardiovascular response

Jeffrey P. Okeson, B.A. Phillips, David T. R. Berry et al. · Journal of Oral Rehabilitation · 1994 · 76 citations

Estimation of Baseline Dopamine D2 Receptor Occupancy in Striatum and Extrastriatal Regions in Humans with Positron Emission Tomography with [18F] Fallypride

Patrizia Riccardi, Ron Baldwin, Ronald M. Salomon et al. · Biological Psychiatry · 2007 · 55 citations

, , +6

Evaluator Training and Reliability for SMA Global Nusinersen Trials

Allan M. Glanzman, Elena Mazzone, Sally Dunaway Young et al. · Journal of Neuromuscular Diseases · 2018 · 54 citations · Full text

A phase I study of ISIS 481464 (AZD9150), a first-in-human, first-in-class, antisense oligonucleotide inhibitor of STAT3, in patients with advanced cancers.

David S. Hong, Anas Younes, Luis Fayad et al. · Journal of Clinical Oncology · 2013 · 17 citations

, , +19

1–4 of 4